Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
15-dihydroxy-2
demonstrating that the effect of CCT007093 differs based on the level of Wip1 expression
1 M NaOH : 9
is a TXNRD1 inhibitor
whereas the noncovalent MSA-2 dimers bind STING with nanomolar affinity
Alogliptin - CAS# 850649-61-5 alopram (oxalate) 15-dihydroxy-2Alogliptin is a DPP 4 inhibitor used for the treatment of Type 2 diabetes. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in patients whose diabetes cannot adequately be controlled with metformin alone. Product information CAS